Mismatch Repair (MMR) Deficiency in Colorectal Cancer

Dr. Sinicrope on Mismatch Repair-Deficient Patients With Metastatic Colorectal Cancer

Dr. Cercek on Induction Chemotherapy in Mismatch Repair Deficient Rectal Cancer

What is microsatellite instability or MSI?

Single-agent PD-1 blockade as curative-intent treatment in mismatch repair-deficient LARC

Dr. Jennifer Wu on Immunotherapy in Mismatch Repair Deficient CRC

MMR by IHC vs MSI by PCR

Debate: MSI High Colon Cancer - Upfront Chemotherapy

Stanford Cancer Institute Breakthroughs in Cancer: Luis Diaz, MD

Improving anti-CTLA4 efficacy in neuroblastoma via the induction of mismatch repair deficiency

Preliminary Findings From the NCI-MATCH Trial for Mismatch Repair-Deficient

Lynch Syndrome: More Than One Syndrome: Constitutional Mismatch Repair Deficiency Syndrome (CMMR-D)

PD-1 Blockade in Locally Advanced Rectal Cancer | NEJM

Immuno-oncology: Cold to Hot Tumours

Advancing Treatment Options for Mismatch Repair-Deficient Metastatic Colorectal Cancers

Dr. Goldberg on PD-1 Blockade in Tumors with Mismatch Repair Deficiency

Dr. Powell on MSI and dMMR as Potential Biomarkers in Endometrial Cancer

Effects of Mismatch Repair Deficiency and Microsatellite Instability on Gastric Cancer Outcomes

Colorectal Cancer: MSI Testing to All Patients and How to Test

Mismatch repair protein loss in breast cancer